1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. New Jersey >
  6. GPC Biotech Acquires Mitotix

M&A Deal Summary

GPC Biotech Acquires Mitotix

On July 24, 2000, GPC Biotech acquired life science company Mitotix

Acquisition Highlights
  • This is GPC Biotech’s 1st transaction in the Life Science sector.
  • This is GPC Biotech’s 1st transaction in the United States.
  • This is GPC Biotech’s 1st transaction in New Jersey.

M&A Deal Summary
Date 2000-07-24
Target Mitotix
Sector Life Science
Buyer(s) GPC Biotech
Deal Type Add-on Acquisition

Target

Mitotix

Princeton, New Jersey, United States
Mitotix is a biopharmaceutical company focused on treatments for cancer and fungal infections.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

GPC Biotech

Princeton, New Jersey, United States
Category Company
Founded 1992
Sector Life Science
DESCRIPTION

GPC Biotech is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: New Jersey M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2000 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal